ATE196256T1 - Hepatotropische konjugaten von antivirale arzneimittel, traeger und pharmazeutische zusammensetzungen - Google Patents
Hepatotropische konjugaten von antivirale arzneimittel, traeger und pharmazeutische zusammensetzungenInfo
- Publication number
- ATE196256T1 ATE196256T1 AT94918793T AT94918793T ATE196256T1 AT E196256 T1 ATE196256 T1 AT E196256T1 AT 94918793 T AT94918793 T AT 94918793T AT 94918793 T AT94918793 T AT 94918793T AT E196256 T1 ATE196256 T1 AT E196256T1
- Authority
- AT
- Austria
- Prior art keywords
- antiviral drugs
- hepatotropic
- conjugates
- carriers
- pharmaceutical compositions
- Prior art date
Links
- 239000003443 antiviral agent Substances 0.000 title abstract 3
- 239000000969 carrier Substances 0.000 title 1
- 230000001553 hepatotropic effect Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- UDMBCSSLTHHNCD-UHTZMRCNSA-N [(2r,3s,4s,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O UDMBCSSLTHHNCD-UHTZMRCNSA-N 0.000 abstract 1
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 abstract 1
- 229960004150 aciclovir Drugs 0.000 abstract 1
- 230000007059 acute toxicity Effects 0.000 abstract 1
- 231100000403 acute toxicity Toxicity 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000021615 conjugation Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229930182830 galactose Natural products 0.000 abstract 1
- 230000002440 hepatic effect Effects 0.000 abstract 1
- 238000007918 intramuscular administration Methods 0.000 abstract 1
- 229920000729 poly(L-lysine) polymer Polymers 0.000 abstract 1
- 229920001308 poly(aminoacid) Polymers 0.000 abstract 1
- 230000008685 targeting Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI931082A IT1270817B (it) | 1993-05-26 | 1993-05-26 | Coniugati di farmaci antivirali ad attivita' epatotropica, relativi veicolanti e composizioni farmaceutiche che li contengono |
| PCT/EP1994/001702 WO1994027642A1 (en) | 1993-05-26 | 1994-05-24 | Hepatotropic conjugates of antiviral drugs, carriers thereof and pharmaceutical compositions containing them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE196256T1 true ATE196256T1 (de) | 2000-09-15 |
Family
ID=11366263
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94918793T ATE196256T1 (de) | 1993-05-26 | 1994-05-24 | Hepatotropische konjugaten von antivirale arzneimittel, traeger und pharmazeutische zusammensetzungen |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0652776B1 (de) |
| JP (1) | JPH07509495A (de) |
| KR (1) | KR100295579B1 (de) |
| AT (1) | ATE196256T1 (de) |
| AU (1) | AU6997094A (de) |
| BR (1) | BR9405378A (de) |
| CA (1) | CA2141028A1 (de) |
| DE (1) | DE69425860T2 (de) |
| ES (1) | ES2152320T3 (de) |
| HU (1) | HU221306B1 (de) |
| IT (1) | IT1270817B (de) |
| PT (1) | PT652776E (de) |
| RU (1) | RU2140292C1 (de) |
| UA (1) | UA47386C2 (de) |
| WO (1) | WO1994027642A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2192250C2 (ru) * | 2000-07-11 | 2002-11-10 | Нижегородский научно-исследовательский кожно-венерологический институт | Способ лечения больных красным плоским лишаем |
| CN103202804A (zh) * | 2013-02-22 | 2013-07-17 | 广东先强药业股份有限公司 | 一种单磷酸阿糖腺苷注射液及其制备方法 |
| US20200101103A1 (en) * | 2017-04-07 | 2020-04-02 | Cirqle Biomedical Contraception Ivs | Reinforcement of mucus barrier properties |
-
1993
- 1993-05-26 IT ITMI931082A patent/IT1270817B/it active IP Right Grant
-
1994
- 1994-05-24 EP EP94918793A patent/EP0652776B1/de not_active Expired - Lifetime
- 1994-05-24 CA CA002141028A patent/CA2141028A1/en not_active Abandoned
- 1994-05-24 PT PT94918793T patent/PT652776E/pt unknown
- 1994-05-24 DE DE69425860T patent/DE69425860T2/de not_active Expired - Fee Related
- 1994-05-24 HU HU9500585A patent/HU221306B1/hu not_active IP Right Cessation
- 1994-05-24 AU AU69970/94A patent/AU6997094A/en not_active Abandoned
- 1994-05-24 BR BR9405378-2A patent/BR9405378A/pt not_active Application Discontinuation
- 1994-05-24 KR KR1019950700270A patent/KR100295579B1/ko not_active Expired - Fee Related
- 1994-05-24 JP JP7500223A patent/JPH07509495A/ja not_active Ceased
- 1994-05-24 ES ES94918793T patent/ES2152320T3/es not_active Expired - Lifetime
- 1994-05-24 UA UA95018079A patent/UA47386C2/uk unknown
- 1994-05-24 WO PCT/EP1994/001702 patent/WO1994027642A1/en not_active Ceased
- 1994-05-24 AT AT94918793T patent/ATE196256T1/de not_active IP Right Cessation
- 1994-05-24 RU RU95105590A patent/RU2140292C1/ru active
Also Published As
| Publication number | Publication date |
|---|---|
| AU6997094A (en) | 1994-12-20 |
| ITMI931082A1 (it) | 1994-11-26 |
| WO1994027642A1 (en) | 1994-12-08 |
| UA47386C2 (uk) | 2002-07-15 |
| ES2152320T3 (es) | 2001-02-01 |
| HU9500585D0 (en) | 1995-04-28 |
| EP0652776B1 (de) | 2000-09-13 |
| KR100295579B1 (ko) | 2001-11-22 |
| KR950702438A (ko) | 1995-07-29 |
| CA2141028A1 (en) | 1994-12-08 |
| PT652776E (pt) | 2001-03-30 |
| JPH07509495A (ja) | 1995-10-19 |
| RU2140292C1 (ru) | 1999-10-27 |
| HUT70481A (en) | 1995-10-30 |
| BR9405378A (pt) | 1999-09-08 |
| RU95105590A (ru) | 1997-02-27 |
| DE69425860T2 (de) | 2001-04-12 |
| DE69425860D1 (de) | 2000-10-19 |
| IT1270817B (it) | 1997-05-09 |
| ITMI931082A0 (it) | 1993-05-26 |
| EP0652776A1 (de) | 1995-05-17 |
| HU221306B1 (en) | 2002-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE68912232D1 (de) | Konjugate zytotoxischer Arzneimittel. | |
| EA200000376A1 (ru) | Полимерные производные камптотецинов | |
| FI945912A0 (fi) | Proteinoidikantajat ja menetelmät niiden valmistamiseksi sekä niiden käyttö | |
| MX169992B (es) | Conjugados de estrella explotada | |
| ATE308998T1 (de) | Langwirkende arzneistoffe und diese enthaltende arzneimittel | |
| KR960702323A (ko) | 폴리머를 사용하는 비타민 b₁₂ 흡수시스템의 증폭 (amplification of the vitamin b₁₂ uptake system using polymers) | |
| ATE238289T1 (de) | Synthese von taxol und deren derivate | |
| DK0473084T3 (da) | Polyethylenglycolderivater, dermed modificerede peptider, fremgangsmåder til fremstilling af disse og anvendelse af de modificerede peptider | |
| DK0960107T3 (da) | 6-Thiosubstituerede paclitaxeler | |
| DK0971717T3 (da) | Cytotoksiske aminosukker- og relaterede sukkerderivater af indolopyrrolocarbazoler | |
| ID28003A (id) | Turunan-turunan adamantana | |
| ITRM940621A0 (it) | "composizione farmaceutica stabilizzata, relativo solvente e procedimento di preparazione" | |
| DK0974366T3 (da) | Orale, farmaceutiske præparater med nedsat bitterhed ved maskering | |
| DK0693924T3 (da) | Fremgangsmåde til (in vivo)-levering af biologiske materialer og sammensætninger, der er egnede dertil | |
| ES2095840T3 (es) | Conjugado de anticuerpo-farmaco. | |
| FR2687151B1 (fr) | Nouveaux derives de la baccatine iii et de la desacetyl-10 baccatine iii, leur preparation et les compositions pharmaceutiques qui les contiennent. | |
| DE69425860D1 (de) | Hepatotropische konjugaten von antivirale arzneimittel, traeger und pharmazeutische zusammensetzungen | |
| DE69132044D1 (de) | Markierte, modifizierte Oligonokleotiden | |
| ATE177632T1 (de) | Antineoplastische pharmazeutische zusammensetzung enthaltend ein fumagillolderivat und einen platinkomplex | |
| DK1011329T3 (da) | 7-Methylthiooxomethyl- og 7-methylthiodioxomethyl-paclitaxeler | |
| Lin et al. | Novel acetylenyl porphyrins: Synthesis, spectroscopy, and electrochemistry | |
| IT8922175A0 (it) | Derivati amminici di 2,3-diaza-antracene-9,10-dioni come farmaci antitumorali | |
| ITMI910600A1 (it) | 6, 9-bis (amino sostituiti) benzo(g) ftalazin-5, 10-dioni come farmaci antitumorali. | |
| NZ335081A (en) | Conjugates containing a cytotoxic drug attached via a bond or linker to an oligopeptide comprising at least one cyclic amino acid having a hydrophilic group useful in the treatment of prostate cancer | |
| MX9303606A (es) | Derivados de azabicicloheptano n-sustituidos, su obtencion y uso. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |